Patheon Softgels Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Patheon Softgels Inc.
Quantité totale PI 79
Rang # Quantité totale PI 17 165
Note d'activité PI 1,9/5.0    12
Rang # Activité PI 72 793
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

52 5
9 5
3 4
1
 
Dernier brevet 2025 - Precipitation inhibitor softgel ...
Premier brevet 1995 - Enrobed tablet
Dernière marque 2014 - LIQUISOFT
Première marque 1999 - SOFLET

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Precipitation inhibitor softgel formulations. Described herein are precipitation inhibitor softge...
Invention Rapid release softgel formulation. A rapid releasing softgel capsule formulation, the formulation...
Invention Liquid dosage forms of sodium naproxen. Described herein are oral pharmaceutical compositions co...
2023 Invention Liquisoft capsules. Described herein are oral pharmaceutical compositions suitable for chewing, s...
2020 Invention Abuse-deterrent compositions. Described herein are abuse deterrent controlled release oral pharm...
2019 Invention Liquisoft capsules. Described herein are oral pharmaceutical compositions suitable for chewing, ...
2018 Invention Liquid dosage forms of sodium naproxen. Described herein are oral pharmaceutical compositions com...
Invention All-natural enteric soft capsules. Described herein are soft capsules and enteric soft capsules c...
Invention Anti-overingestion abuse deterrent compositions. Described herein are abuse deterrent oral pharma...
Invention Non-gelatin enteric soft capsules. Described herein are pharmaceutical enteric soft capsules that...
Invention Silk-based capsules. A hard or soft capsule is disclosed comprising a shell and a fill material, ...
Invention Enteric soft capsules comprising polyunsaturated fatty acids. Described herein are pharmaceutical...
2017 Invention Chewable soft capsules. A matrix formulation for a soft chewable capsule is provided which includ...
Invention Anti-overingestion dosage forms. Described herein are abuse deterrent oral pharmaceutical compos...
Invention Soft lozenge compositions. Described herein are topical, non-systemic, slow releasing oral pharma...
Invention Abuse deterrent dosage forms. Described herein are oral abuse deterrent pharmaceutical compositio...
Invention Soft lozenge compositions. Described herein are oral pharmaceutical compositions suitable for che...
Invention Enteric soft capsule compositions. Described herein are enteric soft capsules comprising gastric ...
Invention Controlled release preparations. Controlled release preparations and soft capsules are provided....
Invention Gastric reflux resistant dosage forms. Gastric resistant film-forming compositions are described ...
Invention Non-burst releasing pharmaceutical composition. Described herein are controlled release oral phar...
2016 Invention Anti-overingestion dosage forms. Described herein are abuse deterrent oral pharmaceutical composi...
Invention Non-systemic topical compositions comprising corticosteroids. Described herein are topical, non-s...
Invention Opioid abuse deterrent dosage forms. Described herein are oral abuse deterrent pharmaceutical com...
Invention Soft lozenges comprising corticosteroids. Described herein are oral pharmaceutical compositions s...
Invention Compositions for colonic delivery of drugs. Described herein are controlled release oral pharmace...
2015 Invention Solvent system for enhancing the solubility of pharmaceutical agents. Liquid and semi-solid pharm...
Invention Enteric soft capsules. A gel mass is provided that is useful in manufacturing enteric soft or ha...
Invention Abuse-deterrent opioids. Described herein are abuse deterrent controlled release oral pharmaceuti...
Invention Enhanced bioavailability of polyunsaturated fatty acids. Described herein are pharmaceutical comp...
Invention All-natural enteric soft capsules comprising active ingredients. Described herein are soft capsu...
Invention Liquid-filled immediate release soft gelatin capsules. Described herein are oral pharmaceutical ...
Invention Abuse-deterrent controlled release formulations. Described herein are abuse deterrent controlled ...
Invention Opioid abuse-deterrent controlled release formulations. Described herein are abuse deterrent cont...
2014 P/S Chewable, liquid-filled pharmaceutical preparations, namely, analgesics, fever reducers; cough, c...
Invention Non-gelatin enteric soft capsules. Enteric soft capsules containing carrageenans as the film-form...
2012 Invention Enteric soft capsules. A gel mass is provided that is useful in manufacturing enteric soft or har...
2008 P/S Enteric film-forming compositions sold as an integral component of capsules, caplets, tablets and...
2007 P/S Chewable film-forming compositions sold as an integral component of encapsulated liquid and semi-...
2004 P/S Film-forming compositions sold as an integral component of capsules, caplets, tablets and encaps...
P/S Film forming compositions comprised of gelatin and non-gelatin polymers sold as an integral compo...
P/S Controlled release film-forming compositions sold as an integral component of capsules, caplets,...
P/S Enteric film-forming compositions sold as an integral component of capsules, caplets, tablets an...
P/S Chewable film-forming compositions sold as an integral component of encapsulated liquid and semi...
2001 P/S Gelatin-coated [ vitamins, ] minerals, herbal and nutritional supplements; pharmaceutical prepara...
2000 P/S Pharmaceutical and veterinary preparations; dietetic substances adapted for medical use, food for...
P/S Gelatin-coated vitamins and minerals; gelatin coating compositions sold as an integral component ...
1999 P/S research, development, and custom formulation of products for others for the pharmaceutical, [ nu...